Chemcrux Enterprises Board of Directors

Get the latest insights into the leadership at Chemcrux Enterprises. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Girishkumar C Shah Chairman & Wholetime Director
Mr. Sanjay Marathe Managing Director
Mr. Sidhdhi G Shah Non Executive Director
Mr. Mukund Bakshi Independent Director
Mr. Shailesh Patel Independent Director
Mr. Bhanubhai Patel Independent Director

Chemcrux Enterprises Share price

CHEMCRUX

119

0.10 (0.08%)
Last updated on 4 Sep, 2025 | 15:28 IST
BUYSELL
Today's High

121.85

Today's Low

117.95

52 Week Low

100.20

52 Week High

229.50

The current prices are delayed, login to your account for live prices

Chemcrux Enterprises FAQs

The board at Chemcrux Enterprises consists of experienced professionals, including Mr. Girishkumar C Shah , Mr. Sanjay Marathe , and others, overseeing the company’s strategic and corporate governance.

Directors at Chemcrux Enterprises are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Girishkumar C Shah is the current chairman at Chemcrux Enterprises.

Executive directors at Chemcrux Enterprises are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Chemcrux Enterprises adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Chemcrux Enterprises, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.